1. Home
  2. TVTX
  3. TVTX News

Latest Travere Therapeutics Inc. (TVTX) News on November 17, 2024

Exploring Three High Growth Tech Stocks in the United States
TVTX

Simply Wall St.

2 days ago

Exploring Three High Growth Tech Stocks in the United States

Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
TVTX

GlobeNewswire

4 days ago

Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Travere Therapeutics Announces Completion of Public Offering of Common Stock and Exercise in Full of Underwriters’ Option to Purchase Additional Shares
TVTX

GlobeNewswire

5 days ago

Travere Therapeutics Announces Completion of Public Offering of Common Stock and Exercise in Full of Underwriters’ Option to Purchase Additional Shares

Travere Therapeutics Announces Pricing of Public Offering of Common Stock
TVTX

GlobeNewswire

9 days ago

Travere Therapeutics Announces Pricing of Public Offering of Common Stock

Travere Therapeutics Announces Proposed Public Offering of Common Stock
TVTX

GlobeNewswire

10 days ago

Travere Therapeutics Announces Proposed Public Offering of Common Stock

Travere Therapeutics to Present at Upcoming Investor Conferences
TVTX

GlobeNewswire

13 days ago

Travere Therapeutics to Present at Upcoming Investor Conferences

Travere Therapeutics Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
TVTX

Simply Wall St.

16 days ago

Travere Therapeutics Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags

Travere Therapeutics Inc (TVTX) Q3 2024 Earnings Call Highlights: Strong Sales Growth Amid ...
TVTX

GuruFocus.com

16 days ago

Travere Therapeutics Inc (TVTX) Q3 2024 Earnings Call Highlights: Strong Sales Growth Amid ...

Travere Therapeutics Reports Third Quarter 2024 Financial Results
TVTX

GlobeNewswire

17 days ago

Travere Therapeutics Reports Third Quarter 2024 Financial Results

Travere Therapeutics Inc (TVTX) Q3 2024 Earnings Report Preview: What to Expect
TVTX

GuruFocus.com

18 days ago

Travere Therapeutics Inc (TVTX) Q3 2024 Earnings Report Preview: What to Expect

Travere presents data reinforcing clinical benefit of FILSPARI in IgAN
TVTX

TipRanks

20 days ago

Travere presents data reinforcing clinical benefit of FILSPARI in IgAN

Travere Therapeutics Presents Data Reinforcing Clinical Benefit of FILSPARI® (Sparsentan) in IgAN and Late-Breaking Presentation in FSGS at ASN Kidney Week 2024
TVTX

GlobeNewswire

22 days ago

Travere Therapeutics Presents Data Reinforcing Clinical Benefit of FILSPARI® (Sparsentan) in IgAN and Late-Breaking Presentation in FSGS at ASN Kidney Week 2024

Travere Therapeutics to Report Third Quarter 2024 Financial Results
TVTX

GlobeNewswire

a month ago

Travere Therapeutics to Report Third Quarter 2024 Financial Results

Travere Therapeutics and CSL Vifor Announce Swissmedic Approval of FILSPARI® (sparsentan) for the Treatment of IgA Nephropathy
TVTX

GlobeNewswire

a month ago

Travere Therapeutics and CSL Vifor Announce Swissmedic Approval of FILSPARI® (sparsentan) for the Treatment of IgA Nephropathy

CSL Vifor and Travere Therapeutics Announce Swissmedic approval of FILSPARI® (sparsentan) for the treatment of IgA Nephropathy
TVTX

CNW Group

a month ago

CSL Vifor and Travere Therapeutics Announce Swissmedic approval of FILSPARI® (sparsentan) for the treatment of IgA Nephropathy

Travere Therapeutics to Present Abstracts at American Society of Nephrology (ASN) Kidney Week 2024
TVTX

GlobeNewswire

a month ago

Travere Therapeutics to Present Abstracts at American Society of Nephrology (ASN) Kidney Week 2024

Travere Therapeutics Inc (TVTX) Q2 2024 Earnings Call Highlights: Strong Revenue Growth Amidst ...
TVTX

GuruFocus.com

a month ago

Travere Therapeutics Inc (TVTX) Q2 2024 Earnings Call Highlights: Strong Revenue Growth Amidst ...

Travere Therapeutics, Inc. (TVTX) Increases R&D Investments Amidst Rising Product Sales
TVTX

Insider Monkey

a month ago

Travere Therapeutics, Inc. (TVTX) Increases R&D Investments Amidst Rising Product Sales

Exploring 3 High Growth Tech Stocks in the United States
TVTX

Simply Wall St.

a month ago

Exploring 3 High Growth Tech Stocks in the United States

Travere Therapeutics Announces Voluntary Pause of Enrollment in the Phase 3 HARMONY Study of Pegtibatinase Related to Commercial Manufacturing Scale-Up
TVTX

GlobeNewswire

2 months ago

Travere Therapeutics Announces Voluntary Pause of Enrollment in the Phase 3 HARMONY Study of Pegtibatinase Related to Commercial Manufacturing Scale-Up

Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
TVTX

GlobeNewswire

2 months ago

Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Travere Therapeutics to Present at the 2024 Cantor Global Healthcare Conference
TVTX

GlobeNewswire

2 months ago

Travere Therapeutics to Present at the 2024 Cantor Global Healthcare Conference

Travere Therapeutics Announces Full FDA Approval of FILSPARI® (sparsentan), the Only Non-Immunosuppressive Treatment that Significantly Slows Kidney Function Decline in IgA Nephropathy
TVTX

GlobeNewswire

2 months ago

Travere Therapeutics Announces Full FDA Approval of FILSPARI® (sparsentan), the Only Non-Immunosuppressive Treatment that Significantly Slows Kidney Function Decline in IgA Nephropathy

High Growth Tech Stocks To Watch In September 2024
TVTX

Simply Wall St.

2 months ago

High Growth Tech Stocks To Watch In September 2024

Travere Therapeutics to Present Abstracts at the Society for the Study of Inborn Errors of Metabolism Annual Symposium 2024
TVTX

GlobeNewswire

3 months ago

Travere Therapeutics to Present Abstracts at the Society for the Study of Inborn Errors of Metabolism Annual Symposium 2024

Travere Therapeutics to Present at Upcoming Investor Conferences
TVTX

GlobeNewswire

3 months ago

Travere Therapeutics to Present at Upcoming Investor Conferences

Travere Therapeutics Second Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
TVTX

Simply Wall St.

3 months ago

Travere Therapeutics Second Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags

Travere Therapeutics Reports Second Quarter 2024 Financial Results
TVTX

GlobeNewswire

4 months ago

Travere Therapeutics Reports Second Quarter 2024 Financial Results

Travere Therapeutics to Report Second Quarter 2024 Financial Results
TVTX

GlobeNewswire

4 months ago

Travere Therapeutics to Report Second Quarter 2024 Financial Results

Travere Therapeutics to Present at the H.C. Wainwright 3rd Annual Kidney Virtual Conference
TVTX

GlobeNewswire

4 months ago

Travere Therapeutics to Present at the H.C. Wainwright 3rd Annual Kidney Virtual Conference

Shareholders in Travere Therapeutics (NASDAQ:TVTX) are in the red if they invested five years ago
TVTX

Simply Wall St.

5 months ago

Shareholders in Travere Therapeutics (NASDAQ:TVTX) are in the red if they invested five years ago

Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
TVTX

GlobeNewswire

5 months ago

Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Intermediate Capital Group plc: Notification of Transactions of Directors
TVTX

GlobeNewswire

5 months ago

Intermediate Capital Group plc: Notification of Transactions of Directors

Argus Research Updated Equity Report Coverage On Tego Cyber Inc.
TVTX

ACCESSWIRE

5 months ago

Argus Research Updated Equity Report Coverage On Tego Cyber Inc.

Lyft stock earns multiple upgrades after investor day
TVTX

Yahoo Finance Video

5 months ago

Lyft stock earns multiple upgrades after investor day

Finally, I can make my iPhone look like total crap
TVTX

Engadget

5 months ago

Finally, I can make my iPhone look like total crap

Stock Split Watch: 3 Growth Stocks That Could Be Next
TVTX

Motley Fool

5 months ago

Stock Split Watch: 3 Growth Stocks That Could Be Next

Intermediate Capital Group plc: Vesting in Share Awards/ Notification of Transactions of Directors
TVTX

GlobeNewswire

5 months ago

Intermediate Capital Group plc: Vesting in Share Awards/ Notification of Transactions of Directors

Tsingke Concludes a Successful Showcase at TIDES USA 2024: Advancing Biotechnology Frontiers
TVTX

PR Newswire

5 months ago

Tsingke Concludes a Successful Showcase at TIDES USA 2024: Advancing Biotechnology Frontiers

Decarbonization of European Refineries: A First Agreement Signed Between TotalEnergies and Air Products for the Delivery of Green Hydrogen
TVTX

Business Wire

5 months ago

Decarbonization of European Refineries: A First Agreement Signed Between TotalEnergies and Air Products for the Delivery of Green Hydrogen

Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
TVTX

GlobeNewswire

6 months ago

Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Travere Therapeutics to Present at National Kidney Foundation Spring Clinical Meetings and the 61st European Renal Association Congress
TVTX

GlobeNewswire

6 months ago

Travere Therapeutics to Present at National Kidney Foundation Spring Clinical Meetings and the 61st European Renal Association Congress

Travere Therapeutics to Present at Upcoming Investor Conferences
TVTX

GlobeNewswire

6 months ago

Travere Therapeutics to Present at Upcoming Investor Conferences

Loss-Making Travere Therapeutics, Inc. (NASDAQ:TVTX) Expected To Breakeven In The Medium-Term
TVTX

Simply Wall St.

6 months ago

Loss-Making Travere Therapeutics, Inc. (NASDAQ:TVTX) Expected To Breakeven In The Medium-Term

TVTX

GuruFocus.com

6 months ago

Travere Therapeutics Inc (TVTX) Q1 2024 Earnings Call Transcript Highlights: Navigating Growth ...

Travere Therapeutics Reports First Quarter 2024 Financial Results
TVTX

GlobeNewswire

6 months ago

Travere Therapeutics Reports First Quarter 2024 Financial Results

Travere Therapeutics to Report First Quarter 2024 Financial Results
TVTX

GlobeNewswire

7 months ago

Travere Therapeutics to Report First Quarter 2024 Financial Results

Travere Therapeutics and CSL Vifor Announce European Commission Approves FILSPARI® (sparsentan) for the treatment of IgA Nephropathy
TVTX

GlobeNewswire

7 months ago

Travere Therapeutics and CSL Vifor Announce European Commission Approves FILSPARI® (sparsentan) for the treatment of IgA Nephropathy

CSL Vifor and Travere Therapeutics Announce European Commission approves FILSPARI® (sparsentan) for the treatment of IgA Nephropathy
TVTX

PR Newswire

7 months ago

CSL Vifor and Travere Therapeutics Announce European Commission approves FILSPARI® (sparsentan) for the treatment of IgA Nephropathy

Travere Therapeutics to Present Abstracts at the Society for Inherited Metabolic Disorders and Genetic Metabolic Dieticians International
TVTX

GlobeNewswire

7 months ago

Travere Therapeutics to Present Abstracts at the Society for Inherited Metabolic Disorders and Genetic Metabolic Dieticians International

Travere Therapeutics to Present Abstracts on FILSPARI® (sparsentan) in IgA Nephropathy at World Congress of Nephrology and the American Nephrology Nurses Association
TVTX

GlobeNewswire

7 months ago

Travere Therapeutics to Present Abstracts on FILSPARI® (sparsentan) in IgA Nephropathy at World Congress of Nephrology and the American Nephrology Nurses Association

Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
TVTX

GlobeNewswire

8 months ago

Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Travere Therapeutics Submits Supplemental New Drug Application to the U.S. Food and Drug Administration Seeking Full Approval of FILSPARI® (sparsentan) for the Treatment of IgA Nephropathy (IgAN)
TVTX

GlobeNewswire

8 months ago

Travere Therapeutics Submits Supplemental New Drug Application to the U.S. Food and Drug Administration Seeking Full Approval of FILSPARI® (sparsentan) for the Treatment of IgA Nephropathy (IgAN)

Travere Therapeutics to Present at Upcoming Investor Conferences
TVTX

GlobeNewswire

9 months ago

Travere Therapeutics to Present at Upcoming Investor Conferences

Travere Therapeutics and CSL Vifor Announce Sparsentan Receives Positive CHMP Opinion for the Treatment of IgA Nephropathy
TVTX

GlobeNewswire

9 months ago

Travere Therapeutics and CSL Vifor Announce Sparsentan Receives Positive CHMP Opinion for the Treatment of IgA Nephropathy

CSL Vifor and Travere Therapeutics announce sparsentan receives positive CHMP opinion for the treatment of IgA nephropathy
TVTX

CNW Group

9 months ago

CSL Vifor and Travere Therapeutics announce sparsentan receives positive CHMP opinion for the treatment of IgA nephropathy

CSL Vifor and Travere Therapeutics announce sparsentan receives positive CHMP opinion for the treatment of IgA nephropathy
TVTX

PR Newswire

9 months ago

CSL Vifor and Travere Therapeutics announce sparsentan receives positive CHMP opinion for the treatment of IgA nephropathy

Travere Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results
TVTX

GlobeNewswire

9 months ago

Travere Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results

Travere Therapeutics to Report Fourth Quarter and Full Year 2024 Financial Results
TVTX

GlobeNewswire

9 months ago

Travere Therapeutics to Report Fourth Quarter and Full Year 2024 Financial Results

Travere Therapeutics to Present at the Guggenheim 6th Annual Biotechnology Conference
TVTX

GlobeNewswire

10 months ago

Travere Therapeutics to Present at the Guggenheim 6th Annual Biotechnology Conference

AMERANT BANK PROVIDES FINANCING TO FRESCO RETAIL GROUP, LLC FOR THE ACQUISITION OF FRESCO Y MÁS OPERATIONS AND LOCATIONS
TVTX

GlobeNewswire

10 months ago

AMERANT BANK PROVIDES FINANCING TO FRESCO RETAIL GROUP, LLC FOR THE ACQUISITION OF FRESCO Y MÁS OPERATIONS AND LOCATIONS

BlueLinx Holdings Inc.'s (NYSE:BXC) Intrinsic Value Is Potentially 21% Below Its Share Price
TVTX

Simply Wall St.

10 months ago

BlueLinx Holdings Inc.'s (NYSE:BXC) Intrinsic Value Is Potentially 21% Below Its Share Price

Travere Therapeutics Announces Licensing Agreement with Renalys Pharma to Develop and Commercialize Sparsentan in Japan, South Korea, Taiwan, and Southeast Asian Nations
TVTX

GlobeNewswire

10 months ago

Travere Therapeutics Announces Licensing Agreement with Renalys Pharma to Develop and Commercialize Sparsentan in Japan, South Korea, Taiwan, and Southeast Asian Nations

ConnectOne Bancorp Inc Reports Mixed Results Amid Industry Challenges
TVTX

GuruFocus.com

10 months ago

ConnectOne Bancorp Inc Reports Mixed Results Amid Industry Challenges

TVTX

GuruFocus.com

10 months ago

First Bancshares Inc (FBMS) Reports Mixed Quarterly Results and Yearly Growth Amid Market Challenges

TVTX

Associated Press Finance

10 months ago

ConnectOne: Q4 Earnings Snapshot

ConnectOne Bancorp, Inc. Reports Fourth Quarter and Full-Year 2023 Results; Declares Common and Preferred Dividends
TVTX

GlobeNewswire

10 months ago

ConnectOne Bancorp, Inc. Reports Fourth Quarter and Full-Year 2023 Results; Declares Common and Preferred Dividends

The First Bancshares (FBMS) Lags Q4 Earnings and Revenue Estimates
TVTX

Zacks

10 months ago

The First Bancshares (FBMS) Lags Q4 Earnings and Revenue Estimates

2 Financial Stocks to Buy After Massive Earnings Beats
TVTX

Zacks

10 months ago

2 Financial Stocks to Buy After Massive Earnings Beats

Veritex Holdings, Inc. Reports Fourth Quarter And Full Year 2023 Results
TVTX

GlobeNewswire

10 months ago

Veritex Holdings, Inc. Reports Fourth Quarter And Full Year 2023 Results

ALLIANCEBERNSTEIN CLOSED-END FUNDS ANNOUNCE DISTRIBUTION RATES
TVTX

PR Newswire

10 months ago

ALLIANCEBERNSTEIN CLOSED-END FUNDS ANNOUNCE DISTRIBUTION RATES

Accolade Welcomes Kindbody to Trusted Partner Ecosystem
TVTX

PR Newswire

10 months ago

Accolade Welcomes Kindbody to Trusted Partner Ecosystem

Establishment Labs Announces Commercial Launch of Motiva Implants in China
TVTX

Business Wire

10 months ago

Establishment Labs Announces Commercial Launch of Motiva Implants in China

Newmark Group's Fourth Quarter and Full Year 2023 Financial Results Announcement to be Issued Prior to Market Open on Thursday, February 22, 2024
TVTX

PR Newswire

10 months ago

Newmark Group's Fourth Quarter and Full Year 2023 Financial Results Announcement to be Issued Prior to Market Open on Thursday, February 22, 2024

LanzaTech Global, Inc. (NASDAQ:LNZA): When Will It Breakeven?
TVTX

Simply Wall St.

10 months ago

LanzaTech Global, Inc. (NASDAQ:LNZA): When Will It Breakeven?

11 Stocks That Will Make You Rich in 5-10 Years
TVTX

Insider Monkey

10 months ago

11 Stocks That Will Make You Rich in 5-10 Years

Service Properties Trust Announces 2023 Dividend Allocation
TVTX

Business Wire

10 months ago

Service Properties Trust Announces 2023 Dividend Allocation

Investors in Equinox Gold (TSE:EQX) have unfortunately lost 51% over the last three years
TVTX

Simply Wall St.

10 months ago

Investors in Equinox Gold (TSE:EQX) have unfortunately lost 51% over the last three years

Upwork Inc. (UPWK) Hit a 52 Week High, Can the Run Continue?
TVTX

Zacks

10 months ago

Upwork Inc. (UPWK) Hit a 52 Week High, Can the Run Continue?

Apple’s VP of finance is the new CFO at Sonos. Here’s what prepared her for the role
TVTX

Fortune

10 months ago

Apple’s VP of finance is the new CFO at Sonos. Here’s what prepared her for the role

NETSTREIT Corp. Announces Pricing of Upsized Forward Common Stock Offering
TVTX

Business Wire

10 months ago

NETSTREIT Corp. Announces Pricing of Upsized Forward Common Stock Offering

Mirum Pharmaceuticals Announces Preliminary Unaudited 2023 Net Revenue and Provides Corporate Updates
TVTX

Business Wire

10 months ago

Mirum Pharmaceuticals Announces Preliminary Unaudited 2023 Net Revenue and Provides Corporate Updates

Travere Therapeutics Provides Corporate Update and 2024 Outlook
TVTX

GlobeNewswire

10 months ago

Travere Therapeutics Provides Corporate Update and 2024 Outlook

Avidity Biosciences Announces 2024 Corporate Priorities and Catalysts for Next Stage of Growth
TVTX

PR Newswire

10 months ago

Avidity Biosciences Announces 2024 Corporate Priorities and Catalysts for Next Stage of Growth

Shipping stocks jump as freight costs soar amid Red Sea tensions
TVTX

Yahoo Finance

10 months ago

Shipping stocks jump as freight costs soar amid Red Sea tensions

Travere Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference
TVTX

GlobeNewswire

10 months ago

Travere Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference

Is There An Opportunity With Monarch Casino & Resort, Inc.'s (NASDAQ:MCRI) 28% Undervaluation?
TVTX

Simply Wall St.

a year ago

Is There An Opportunity With Monarch Casino & Resort, Inc.'s (NASDAQ:MCRI) 28% Undervaluation?

WalkMe Survey Shows Half of Workers Don’t File Expense Reports, Leaving Billions of Dollars on the Table
TVTX

GlobeNewswire

a year ago

WalkMe Survey Shows Half of Workers Don’t File Expense Reports, Leaving Billions of Dollars on the Table

Here's Why We Think Cheesecake Factory (NASDAQ:CAKE) Is Well Worth Watching
TVTX

Simply Wall St.

a year ago

Here's Why We Think Cheesecake Factory (NASDAQ:CAKE) Is Well Worth Watching

Travere Therapeutics Initiates Pivotal Phase 3 Clinical Trial of Pegtibatinase for the Treatment of Classical Homocystinuria (HCU)
TVTX

GlobeNewswire

a year ago

Travere Therapeutics Initiates Pivotal Phase 3 Clinical Trial of Pegtibatinase for the Treatment of Classical Homocystinuria (HCU)

TriMas Packaging Selected to Partner With Leading Food and Beverage Brands
TVTX

Business Wire

a year ago

TriMas Packaging Selected to Partner With Leading Food and Beverage Brands

12 Best Junior Silver Mining Stocks To Buy Now
TVTX

Insider Monkey

a year ago

12 Best Junior Silver Mining Stocks To Buy Now

TVTX

GlobeNewswire

a year ago

Oxford Lane Capital Corp. Provides November Net Asset Value Update

TVTX

PR Newswire

a year ago

SABINE ROYALTY TRUST ANNOUNCES MONTHLY CASH DISTRIBUTION FOR DECEMBER 2023

Travere Completes Successful pre-NDA Meeting for FILSPARI in IgAN; Provides Regulatory Updates for both IgAN and FSGS
TVTX

GlobeNewswire

a year ago

Travere Completes Successful pre-NDA Meeting for FILSPARI in IgAN; Provides Regulatory Updates for both IgAN and FSGS

Travere Therapeutics (NASDAQ:TVTX) shareholders have endured a 74% loss from investing in the stock three years ago
TVTX

Simply Wall St.

a year ago

Travere Therapeutics (NASDAQ:TVTX) shareholders have endured a 74% loss from investing in the stock three years ago

Travere Therapeutics to Present at the 6th Annual Evercore ISI HealthCONx Conference
TVTX

GlobeNewswire

a year ago

Travere Therapeutics to Present at the 6th Annual Evercore ISI HealthCONx Conference

Miller Children's & Women's Announces New Miller Children's & Women's Neonatal Network in Partnership with Pediatrix Medical Group, Dr. Antoine Soliman Named Regional Medical Director
TVTX

PR Newswire

a year ago

Miller Children's & Women's Announces New Miller Children's & Women's Neonatal Network in Partnership with Pediatrix Medical Group, Dr. Antoine Soliman Named Regional Medical Director

Pediatrix Medical Group, Inc. (NYSE:MD) Shares Could Be 47% Below Their Intrinsic Value Estimate
TVTX

Simply Wall St.

a year ago

Pediatrix Medical Group, Inc. (NYSE:MD) Shares Could Be 47% Below Their Intrinsic Value Estimate

Should You Invest in Definitive Healthcare Corp. (DH)?
TVTX

Insider Monkey

a year ago

Should You Invest in Definitive Healthcare Corp. (DH)?

Share on Social Networks: